Actinic keratosis: New concept and therapeutic update

Actinic keratosis (AK) is a common reason for consultation in both Primary Care and Specialised Care. It is the third or fourth most common reason for consultation in dermatology, accounting for up to 5-6% of patients attended. It has also been observed that its prevalence has been increasing in the...

Descripción completa

Detalles Bibliográficos
Autores: Carmena-Ramón R, Mateu-Puchades A, Santos-Alarcón S, Lucas-Truyols S
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p1982
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/1982
Access Level:acceso abierto
Palabra clave:Actinic keratosis
Treatment
Cancerisation field
id ES_56db889ebfa7aa680a6133e048b4e24e
oai_identifier_str oai:fisabio.fundanetsuite.com:p1982
network_acronym_str ES
network_name_str España
repository_id_str
spelling Actinic keratosis: New concept and therapeutic updateCarmena-Ramón RMateu-Puchades ASantos-Alarcón SLucas-Truyols SActinic keratosisTreatmentCancerisation fieldActinic keratosis (AK) is a common reason for consultation in both Primary Care and Specialised Care. It is the third or fourth most common reason for consultation in dermatology, accounting for up to 5-6% of patients attended. It has also been observed that its prevalence has been increasing in the last 10 years, compared to other dermatoses. This is also expected to continue to increase due to longer life expectancy, and by the changes in sun exposure habits since the middle of the last century. The aim of this article is "to update the concepts of AK, cancerisation field and to present the currently available therapeutic tools." (C) 2017 Published by Elsevier Espana, S.L.U.EDICIONES DOYMA S A2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/1982Atencion PrimariaISSN: 02126567ISSNe: 15781275reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Españolinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p19822026-06-11T12:45:17Z
dc.title.none.fl_str_mv Actinic keratosis: New concept and therapeutic update
title Actinic keratosis: New concept and therapeutic update
spellingShingle Actinic keratosis: New concept and therapeutic update
Carmena-Ramón R
Actinic keratosis
Treatment
Cancerisation field
title_short Actinic keratosis: New concept and therapeutic update
title_full Actinic keratosis: New concept and therapeutic update
title_fullStr Actinic keratosis: New concept and therapeutic update
title_full_unstemmed Actinic keratosis: New concept and therapeutic update
title_sort Actinic keratosis: New concept and therapeutic update
dc.creator.none.fl_str_mv Carmena-Ramón R
Mateu-Puchades A
Santos-Alarcón S
Lucas-Truyols S
author Carmena-Ramón R
author_facet Carmena-Ramón R
Mateu-Puchades A
Santos-Alarcón S
Lucas-Truyols S
author_role author
author2 Mateu-Puchades A
Santos-Alarcón S
Lucas-Truyols S
author2_role author
author
author
dc.subject.none.fl_str_mv Actinic keratosis
Treatment
Cancerisation field
topic Actinic keratosis
Treatment
Cancerisation field
description Actinic keratosis (AK) is a common reason for consultation in both Primary Care and Specialised Care. It is the third or fourth most common reason for consultation in dermatology, accounting for up to 5-6% of patients attended. It has also been observed that its prevalence has been increasing in the last 10 years, compared to other dermatoses. This is also expected to continue to increase due to longer life expectancy, and by the changes in sun exposure habits since the middle of the last century. The aim of this article is "to update the concepts of AK, cancerisation field and to present the currently available therapeutic tools." (C) 2017 Published by Elsevier Espana, S.L.U.
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/1982
url https://fisabio.portalinvestigacion.com/publicaciones/1982
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv EDICIONES DOYMA S A
publisher.none.fl_str_mv EDICIONES DOYMA S A
dc.source.none.fl_str_mv Atencion Primaria
ISSN: 02126567
ISSNe: 15781275
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869408409610092544
score 15,812429

Similares en LA Referencia